Drug injury lawsuits seeking compensation for patients with Wegovy and Ozempic eye damage side effects have been filed against the pharmaceutical company Novo Nordisk. These Wegovy and Ozempic eye damage lawsuits have received a boost, it seems, from some recent news out of Europe. From this … More
Main Navigation Menu
➤ About the Law Offices of Thomas J. Lamb
PRACTICE AREAS
➤ Asbestos and Mesothelioma Claims
➤ Benzene Cancer and Disease Claims
➤ Pharmaceutical Drug Injury Lawsuits
➤ Breast Implants Lymphoma Cancer Lawsuits
➤ Free Case Evaluation by Lawyer Tom Lamb
INFORMATION
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Our "Recent Articles" Archives
To save time, you can use our Quick Contact Form to tell us about your possible case.
Recent Articles
Depo-Provera: Two Risk Factors for Meningioma Identified in 2025
A new 2025 medical study about Depo-Provera (depot medroxyprogesterone acetate) identified two risk factors for meningioma, a side effect associated with Depo-Provera injections. An article in the November 2025 edition of the medical journal JAMA Neurology, “Depot Medroxyprogesterone Acetate and … More
A Case of Primary Malignant Peritoneal Mesothelioma
Primary malignant mesothelioma (MPM) is a rare malignancy that arises from the epithelial cells that line visceral cavities. The primary pleural presentation is known as the most commonly seen presentation and is best recognized clinically. Less commonly, mesothelioma can arise from epithelial cells … More
GLP-1 RA Drug NAION Cases: Medical and Legal Updates October 2025
GLP-1 RA Drug NAION Cases: Possible Drug Injury Lawsuits We are investigating possible drug injury lawsuits where people using glucagon-like peptide-I receptor agonist (GLP-1 RA) drugs were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION), resulting in vision loss or … More
Dupixent Legal and Medical Information About T-cell Lymphoma
In this brief article, we present important Dupixent legal and medical information about T-cell lymphoma, which appears to be a Dupixent-related side effect. We start with some of the allegations contained in the lawsuits being filed against the pharmaceutical companies Regeneron Pharmaceuticals, … More
Chrysotile asbestos—the deadly consequences of a retreat from national bans
Many in the global clinical and research community reacted with horror to the June 18, 2025, news that the Trump administration was requesting that the US Environmental Protection Agency (US EPA) should “reconsider” the country’s ban on chrysotile asbestos. This ban had been previously enacted under … More